BioSpace News Archive

Clinical-stage biotech company Celcuity announced Thursday that it had entered into a global licensing agreement with Pfizer to develop and commercialize gedatolisib, the latter company’s first-in-class PI3K/mTOR inhibitor for the treatment of breast cancer.

Palleon Pharmaceuticals, a company pioneering the field of glycan-mediated immune regulation to treat cancer and inflammatory diseases, announced the presentation of data supporting the role of hypersialylation in the immune escape of metastatic melanoma at the AACR Annual Meeting held virtually April 10-15, 2021.

Company’s technologies and drug-hunting expertise now responsible for world’s first and second AI-designed drugs to enter Phase I testing

Chemotherapy is a process that uses drugs for the control, cure, and palliation of cancer. Cancer, in its early stages, can be cured and controlled using chemotherapy.

Growing mortality rate as a result of surging cancer cases is prompting manufacturers to develop advanced devices for early screening and detection

The global healthcare satellite connectivity market has grown over the years and is expected to progress in the near term as well.

Sternal closures are used to close the sternum after cardiac surgery. In this technique, steel wires are wrapped around the halves of the sternum to close it.

The rising number of road accidents, coupled with the increasing popularity of medical tourism worldwide is a prime factor boosting the growth of the global ambulance services market during the forecast period, set between 2020 and 2030.

Hansa Biopharma AB, Reg. No. 556734-5359, with registered office in Lund, gives notice to Annual General Meeting on Wednesday May 12, 2021.

MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced translational data supporting the favourable immunological effects of MTL-CEBPA and its benefits in combination with other cancer therapies including anti-PD1 checkpoint inhibition.